露笑科技(002617.SZ):露超投資擬對東方佳軒增資4000萬元
格隆匯2月5日丨露笑科技(002617.SZ)公佈,此前披露,公司的全資子公司浙江露超投資管理有限公司(簡稱“露超投資”)出資人民幣6,000萬元參與海南東方佳軒企業管理諮詢中心(有限合夥)(簡稱“東方佳軒”)增資。東方佳軒增資完成後出資額增加為54,701萬元,露超投資出資佔比為10.97%。
露超投資將繼續出資人民幣4,000萬元對東方佳軒進行增資,東方佳軒本次增資完成後總出資額增加為58,701萬元,露超投資合計出資10,000萬元,佔比為17.04%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.